Choice and validation of a near infrared spectroscopic application for the identity control of starting materials
| Autor: | Vredenbregt Mj, Ronald Hoogerbrugge, D.M. Barends, P.W.J Caspers |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Computer science
business.industry Near-infrared spectroscopy Pharmaceutical Science General Medicine Marketing authorization computer.software_genre Identification (information) Identity (object-oriented programming) media_common.cataloged_instance Second derivative spectra Data mining European union business computer Smoothing Biotechnology media_common Pharmaceutical industry |
| Zdroj: | European Journal of Pharmaceutics and Biopharmaceutics. 56:489-499 |
| ISSN: | 0939-6411 |
| Popis: | Recently the CPMP/CVMP sent out for consultation the draft Note for Guidance (dNfG) on the use of near infrared spectroscopy (NIRS) by the pharmaceutical industry and the data to be forwarded in part II of the dossier for a marketing authorization. We explored the practicability of this dNfG with respect to the verification of the correct identity of starting materials in a generic tablet-manufacturing site. Within the boundaries of the dNfG, a release procedure was developed for 12 substances containing structurally related compounds and substances differing only in particle size. For the method development literature data were also taken into consideration. Good results were obtained with wavelength correlation (WC), applied on raw spectra or second derivative spectra both without smoothing. The defined threshold of 0.98 for raw spectra differentiated between all molecular structures. Both methods were found to be robust over a period of 1 year. For the differentiation between the different particle sizes a subsequent second chemometric technique had to be used. Soft independent modelling of class analogy (SIMCA) with a probability level of 0.01 proved suitable. Internal and external validation I according to the dNfG showed no incorrect rejections or false acceptances. External validation II according to the dNfG was carried out with 95 potentially interfering substances from which 46 were tested experimentally. Macrogol 400 was not distinguished from macrogol 300. For the complete verification of the identity of macrogol 300 test A of the European Pharmacopoeia is needed in addition to the NIRS application. A release procedure developed with WC applied on raw spectra and SIMCA as a second method, which is different from the preferred method of the dNfG, was tested in practice with good results. We conclude that the dNfG has good practicability and that deviations from the preferred methods of the dNfG can also give good differentiation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect